BioAegis Therapeutics
Morristown, US · Founded 2011 · Delaware corporation
Biotech
Founders & leadership
TS
Thomas StosselDirector
SL
Susan LevinsonExecutive Officer, Director
VC
Valerie CevaExecutive Officer, Director
SC
Steve CordovanoExecutive Officer
Reported raises · per SEC filings
Form D private placements▶$21.8MraisedMay 2022 · 27 investors · BiotechnologyRule 506(b)
▶$21.8MraisedMay 2022 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Valerie CevaExecutive Officer, Director
- Mark DiNubileExecutive Officer, Director
- Susan LevinsonExecutive Officer, Director
- Offering amount
- $21.8M
- Amount sold
- $21.8M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedOct 2020 · 147 investors · BiotechnologyRule 506(b)
▶$7MraisedOct 2020 · 147 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Susan LevinsonExecutive Officer, Director
- John StosselDirector
- Mark DiNubileExecutive Officer, Director
- Valerie CevaExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedSep 2018 · 10 investors · BiotechnologyRule 506(b)
▶$4.1MraisedSep 2018 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark DiNubileExecutive Officer
- Thomas StosselExecutive Officer, Director
- Valerie CevaExecutive Officer, Director
- Susan LevinsonExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $4.1M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2016 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven CordovanoExecutive Officer
- Thomas StosselExecutive Officer, Director
- Susan LevinsonExecutive Officer, Director
- Valerie CevaExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.5M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedApr 2015 · 77 investors · BiotechnologyRule 506(b)
▶$8MraisedApr 2015 · 77 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Valerie CevaExecutive Officer, Director
- Thomas StosselDirector
- Susan LevinsonExecutive Officer, Director
- Steve CordovanoExecutive Officer
- Amount sold
- $8M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.